Hypoglycaemia in a patient with diabetes
125 results
1 - 100
Hypoglycaemia in a patient with diabetes - Hypoglycaemia in the absence of diabetes in adults
- Pancreatic insufficiency
- Diabetic ketoacidosis
- Type 1 diabetes: treatment
- Curable causes of cognitive challenges and memory disease
(Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus- Continuous glucose monitoring systems for type 1 diabetes mellitus
- Comprehensive treatment and follow-up of type 2 diabetes
- Diabetic kidney disease (diabetic nephropathy)
- Sulphonylurea monotherapy for patients with type 2 diabetes mellitus: Cochrane systematic review
Tight control associated with more frequent and persistent hypoglycemia in elderly persons with diabetes mellitus- (Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus
- Follow-up of type 1 diabetes
- Interventions for people with type 2 diabetes mellitus fasting during Ramadan
- Insulin therapy in type 2 diabetes
- Diabetes: definition, differential diagnosis and classification
- Chronic pancreatitis
- Regular check-ups of patients with diabetes
- Pioglitazone for type 2 diabetes mellitus
- Meglitinide analogues (glinides) for type 2 diabetes mellitus
- Insulin for glycaemic control in acute ischaemic stroke: Cochrane systematic review
- Intermediate acting versus long acting insulin for type 1 diabetes mellitus
- 'Human' insulin versus animal insulin in people with diabetes mellitus
- Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
- Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus: Cochrane systematic review
- Dipeptidyl peptidase‐4 (DPP‐4) inhibitors for type 2 diabetes mellitus
- Inhaled insulin in diabetes mellitus: Cochrane systematic review
- Excessive sweating (hyperhidrosis)
- Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus
- Different intensities of glycaemic control for pregnant women with pre-existing diabetes
- Continuous subcutaneous insulin infusion for type 1 diabetes
- Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia
- Sulphonylurea for type 2 diabetes
- Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients
- A child or adolescent with type 1 diabetes in primary health care
- Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus
- Routine hospital admission versus out‐patient or home care in children at diagnosis of type 1 diabetes mellitus
- Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents
- Specialist nurses in diabetes mellitus: Cochrane systematic review
- Intermediate acting versus (ultra-)long acting insulin for type 1 diabetes mellitus
- Education programmes for people with chronic kidney disease and diabetes
- Insulin detemir versus insulin glargine for type 2 diabetes mellitus: Cochrane systematic review
- Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus: Cochrane systematic review
- Glucagon‐like peptide 1 (GLP‐1) receptor agonists for people with chronic kidney disease and diabetes
- Meglitinide analogues for type 2 diabetes mellitus
- Glucose targets for preventing diabetic kidney disease and its progression
- Headache
- Continuous subcutaneous insulin infusion for pregnant women with diabetes
- Short‐acting insulin analogues versus regular human insulin for adult, non‐pregnant persons with type 2 diabetes mellitus
- Metformin and second‐ or third‐generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus
- Low glycaemic index, or low glycaemic load, diets for diabetes mellitus
- Sodium‐glucose co‐transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes
- Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus
- Nausea and vomiting
- Diarrhoea and vomiting in children
- Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin: Cochrane systematic review
- Gestational diabetes mellitus (GDM)
- Effect of the treatment of type 2 diabetes mellitus on the development of cognitive impairment and dementia
- Insulin versus oral anti-diabetic pharmacological therapies for gestational diabetes